CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2009-09-17): Exercise, even without weight loss, reduces obesity-related fatty liver

Clinical

Exercise, even without weight loss, reduces obesity-related fatty liver

Last Updated: 2009-09-17 14:30:40 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Regular aerobic exercise reduces fatty liver in obese individuals, even without changes in body weight or abdominal fat, Australian researchers report.

"Weight loss is often the primary intent for prescribing lifestyle therapy in the management of obesity-related fatty liver disease," lead researcher Dr. Nathan A. Johnson of the University of Sydney noted in an email to Reuters Health. "Yet, it is now recognized that being physically fit can protect against cardio-metabolic risk, independent of adiposity," he added.

As reported in the October issue of Hepatology, Dr. Johnson and colleagues used magnetic resonance imaging and proton magnetic resonance spectroscopy to assess the effect of aerobic training on hepatic, blood, abdominal and muscle lipids in 19 obese sedentary adults.

Twelve participants were assigned to a 4-week aerobic cycling program and 7 followed a home stretching routine (the control group).

After 4 weeks, body weight and body mass index remained unchanged, but cardiorespiratory fitness improved significantly in the exercise group versus the control group, the team reports.

Moreover, compared to baseline, the researchers noted a 21% reduction in hepatic triglycerides, a 12% decline in visceral adipose tissue and a 14% reduction in plasma free fatty acids in the aerobic exercise group.

"We have shown that exercise imparts a direct hepatic benefit in non-alcoholic fatty liver disease," Dr. Johnson told Reuters Health.

"The benefit was achieved using an exercise dose on the lower end of the range currently recommended for health promotion, and significantly lower than that advocated for the management of overweight and obesity," he added.

This finding, Dr. Johnson concluded, "is important not just for reducing the burden of liver-related morbidity and mortality, but also for the broader obesity, cardiovascular disease and insulin resistance epidemics, in which hepatic steatosis plays a central role."

Hepatology 2009.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.